The first case was an arthroscopic ankle fusion, according to a news release. OssiGraft Prime is derived from donors with a median age of 35 and a maximum age of 55, and it has a high composition of cancellous bone to promote faster bone regeneration.
OssiGraft Prime is available nationwide to orthopedic surgeons.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
